FDA Inspection
Kappa Laboratories, Inc.Kappa Laboratories, Inc. – FDA Inspection, Apr 22, 2022
Record Details
This FDA Inspection record concerns Kappa Laboratories, Inc., with an inspection on April 22, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Kappa Laboratories, Inc.
- Inspection Date
- April 22, 2022
- Product Type
- Drugs
View Company Profile
ID · 274e2edb-065e-41c1-bfb4-3744dbfe2906
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1167681
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Kappa Laboratories, Inc.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2025 | VAI | Florida District Office | Drug Quality Assurance |
| August 25, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Kappa Laboratories, Inc.
- FDA Inspection 1271683 - 2025-06-04
- FDA Inspection 1029683 - 2017-08-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.